Table 2.
COVID-19 treatment | CAPA (n = 16) | Controls (n = 67) | P-value |
---|---|---|---|
Hydroxychloroquine | 14 (88) | 56 (84) | 0.71 |
Lopinavir/ritonavir | 11 (69) | 45 (67) | 0.91 |
Azithromycin | 12 (75) | 56 (84) | 0.43 |
Steroids | 2 (13) | 22 (33) | 0.34 |
Tocilizumab | 12 (75) | 43 (64) | 0.52 |
Here we show the COVID-19 treatment received by each group. There were no significant differences in the frequencies in which COVID-19 treatment was administered among both groups. All values are N (%).